FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Micro Labs Telmisartan Tablets Recall

Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro L…

Micro Labs Limited · Verna, N/A

Risk level
Class II
Reported by FDA
Mar 20, 2024
Recall ID
D-0388-2024
Check your lot numberHow we source this data

Summary

Micro Labs recalled Telmisartan Tablets starting Feb 9, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0388-2024 on Mar 20, 2024. Reason: Failed Stability Specifications: Out of specification for blend uniformity. Status: Terminated.

Why it was recalled

Failed Stability Specifications: Out of specification for blend uniformity.

Product description

Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.

Lot numbers, UPCs & expiration codes

Lot #s: SFBG024, SFBG025, Exp. 05/31/2024

Where it was sold

Puerto Rico, TN, RI

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0388-2024
Classification
Class II
Status
Terminated
Recall initiated
Feb 9, 2024
FDA report date
Mar 20, 2024
Quantity
118,080 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Micro Labs Limited

Original FDA data

Every field from FDA enforcement report D-0388-2024, exactly as published.

Show all FDA fields
City
Verna
Status
Terminated
Country
India
Event ID
93965
Address
Plot# S - 155
Address (line 2)
& N1 Phase Iii & Phase Iv; Verna Ind Estate Road
Code information
Lot #s: SFBG024, SFBG025, Exp. 05/31/2024
Report date
Mar 20, 2024
Product type
Drugs
Recall number
D-0388-2024
Classification
Class II
Recalling firm
Micro Labs Limited
Product quantity
118,080 bottles
Termination date
Jun 24, 2025
Reason for recall
Failed Stability Specifications: Out of specification for blend uniformity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.
Distribution pattern
Puerto Rico, TN, RI
Recall initiation date
Feb 9, 2024
Initial firm notification
Letter
Center classification date
Mar 14, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0388-2024, published Mar 20, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls